Chinese Journal of Antituberculosis ›› 2020, Vol. 42 ›› Issue (10): 1029-1035.doi: 10.3969/j.issn.1000-6621.2020.10.005
• Original Articles • Previous Articles Next Articles
FAN Li-chao, WU Hao-yu, CHENG Mo-xin, YANG Yi-fan, WANG Xiao-hong, YU Yan-hong, CHEN Yu()
Received:
2020-07-04
Online:
2020-10-10
Published:
2020-10-15
Contact:
CHEN Yu
E-mail:yuchensyxk@163.com
FAN Li-chao, WU Hao-yu, CHENG Mo-xin, YANG Yi-fan, WANG Xiao-hong, YU Yan-hong, CHEN Yu. Analysis of characteristics and related factors of tuberculosis resistance in children[J]. Chinese Journal of Antituberculosis, 2020, 42(10): 1029-1035. doi: 10.3969/j.issn.1000-6621.2020.10.005
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2020.10.005
耐药顺位 | 总体(314例)耐药 | 初治(253例)耐药 | 复治(61例)耐药 | |||||||
---|---|---|---|---|---|---|---|---|---|---|
药品 | 例数 | 耐药率(%) | 药品 | 例数 | 耐药率(%) | 药品 | 例数 | 耐药率(%) | ||
1 | Sm | 60 | 19.1 | Sm | 38 | 15.0 | INH | 25 | 41.0 | |
2 | INH | 58 | 18.5 | INH | 33 | 13.0 | RFP | 22 | 36.1 | |
3 | RFP | 45 | 14.3 | RFP | 23 | 9.1 | Sm | 22 | 36.1 | |
4 | Lfx | 12 | 3.8 | Lfx | 7 | 2.8 | EMB | 6 | 9.8 | |
5 | EMB | 10 | 3.2 | EMB | 4 | 1.6 | Lfx | 5 | 8.2 | |
6 | Am | 3 | 1.0 | Am | 1 | 0.4 | Am | 2 | 3.3 | |
7 | Mfx | 1 | 0.3 | Mfx | 1 | 0.4 | Mfx | 0 | 0.0 | |
8 | Lzd | 1 | 0.3 | Lzd | 1 | 0.4 | Lzd | 0 | 0.0 | |
9 | Pto | 1 | 0.3 | Pto | 1 | 0.4 | Pto | 0 | 0.0 |
因素 | 例数 | 耐多药例数 | 耐多药率(%) | χ2值 | P值 |
---|---|---|---|---|---|
性别 | 0.218 | 0.641 | |||
女 | 136 | 16 | 11.8 | ||
男 | 178 | 18 | 10.1 | ||
年龄组(岁) | 10.322 | 0.042 | |||
<14 | 33 | 5 | 15.2 | ||
14~18 | 281 | 29 | 10.3 | ||
吸烟 | 14.235 | 0.030 | |||
否 | 302 | 30 | 9.9 | ||
是 | 12 | 4 | 33.3 | ||
营养不良 | 5.562 | 0.031 | |||
否 | 261 | 27 | 10.3 | ||
是 | 53 | 7 | 13.2 | ||
治疗史 | 27.360 | 0.000 | |||
初治 | 253 | 16 | 6.3 | ||
复治 | 61 | 18 | 29.5 | ||
居住地 | 3.422 | 0.071 | |||
农村 | 167 | 13 | 7.8 | ||
城镇 | 147 | 21 | 14.3 | ||
规律用药 | 13.511 | 0.002 | |||
否 | 29 | 9 | 31.0 | ||
是 | 285 | 25 | 8.8 | ||
接触史 | 124.566 | 0.000 | |||
否 | 273 | 21 | 7.7 | ||
是 | 41 | 13 | 31.7 |
影响因素 | β值 | Wald χ2值 | P值 | OR值 | 95%CI值 | |
---|---|---|---|---|---|---|
年龄(以<14岁组为参照) | ||||||
14~18岁 | 1.449 | 1.032 | 2.398 | 0.032 | 2.235 | 1.568~3.562 |
有吸烟史 | 0.203 | 0.106 | 2.530 | 0.046 | 1.225 | 1.013~2.740 |
治疗史(以初治组为参照) | ||||||
复治 | 1.735 | 0.477 | 13.256 | 0.000 | 5.671 | 2.228~14.435 |
营养不良 | -0.097 | 0.506 | 10.370 | 0.034 | 1.908 | 1.337~2.447 |
居住地(以农村组为参照) | ||||||
城镇 | 0.774 | 0.399 | 3.758 | 0.053 | 2.168 | 0.991~4.740 |
规律用药 | -0.349 | 0.561 | 0.387 | 0.534 | 0.705 | 0.235~2.118 |
有结核病患者接触史 | -6.495 | 1.250 | 26.998 | 0.000 | 0.002 | 0.000~0.018 |
[1] |
Dodd PJ, Sismanidis C, Seddon JA. Global burden of drug-resistant tuberculosis in children: a mathematical modelling study. Lancet Infect Dis, 2016,16(10):1193-1201. doi: 10.1016/S1473-3099(16)30132-3.
doi: 10.1016/S1473-3099(16)30132-3 URL pmid: 27342768 |
[2] |
Jenkins HE, Tolman AW, Yuen CM, et al. Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet, 2014,383(9928):1572-1579. doi: 10.1016/S0140-6736(14)60195-1.
doi: 10.1016/S0140-6736(14)60195-1 URL |
[3] |
Jenkins HE, Yuen CM. The burden of multidrug-resistant tuberculosis in children. Int J Tuberc Lung Dis, 2018,22(5):3-6. doi: 10.5588/ijtld.17.0357.
doi: 10.5588/ijtld.17.0357 URL pmid: 29665947 |
[4] |
Guo Q, Pan Y, Yang Z, et al. Epidemiology and Clinical Characteristics of Pediatric Drug-Resistant Tuberculosis in Chongqing, China. PLoS One, 2016,11(3):e0151303. doi: 10.1371/journal.pone.0151303.
doi: 10.1371/journal.pone.0151303 URL pmid: 26959480 |
[5] | 彭哲, 刘芮汐, 李奇志, 等. 儿童结核病耐药状况及危险因素分析. 中国微生态学杂志, 2011,23(7):644-646. |
[6] |
Tao NN, He XC, Zhang XX, et al. Drug-Resistant Tuberculosis among Children, China, 2006—2015. Emerg Infect Dis, 2017,23(11):1800-1805. doi: 10.3201/eid2311.170234.
doi: 10.3201/eid2311.170234 URL pmid: 29047424 |
[7] | 中华人民共和国国家卫生和计划生育委员会. WS 196—2017结核病分类. 2017-11-09. |
[8] | WHO multicentre growth reference study group. WHO Child Growth Standards based on length/height,weight and age. Acta Pediatrica, 2006,64(2):76-85. doi: 10.1111/j.1651-2227.2006.tb02378.x. |
[9] | 袁平, 王晓莉, 王燕. 我国常用的三种儿童生长发育评价标准的比较. 中国儿童保健杂志, 2008,16(6):7682-684. doi: 10.3969/j.issn.1008-6579.2008.06.025. |
[10] | 中国防痨协会. 结核病诊断细菌学检验规程. 中国防痨杂志, 1996,18(2):127-134. |
[11] | World Health Organization. Global tuberculosis report 2019. Geneva: World Health Organization, 2019. |
[12] |
Kim HJ, Yoon HH, Eun BW, et al. The Rate of Drug-Resis-tant Tuberculosis in Korean Children and Adolescents Since 2007. J Korean Med Sci, 2017,32(6):954-960. doi: 10.3346/jkms.2017.32.6.954.
doi: 10.3346/jkms.2017.32.6.954 URL pmid: 28480653 |
[13] |
Fairlie L, Beylis NC, Reubenson G, et al. High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study. Bmc Infectious Diseases, 2011,11:28. doi: 10.1186/1471-2334-11-28.
doi: 10.1186/1471-2334-11-28 URL pmid: 21269475 |
[14] |
Jiao WW, Liu ZG, Han R, et al. Prevalence of drug resistant Mycobacterium tuberculosis among children in China. Tuberculosis, 2015,95(3):315-320. doi: 10.1016/j.tube.2015.02.041.
doi: 10.1016/j.tube.2015.02.041 URL pmid: 25814302 |
[15] | 钟威, 杨立军, 何琳, 等. 辽宁省肺结核患者耐药状况及相关因素分析. 中国热带医学, 2017,17(3):221-225. doi: 10.13604/j.cnki.46-1064/r.2017.03.03. |
[16] | 高谦, 梅建. 传播才是造成我国结核病高耐药率的主要原因. 中国防痨杂志, 2015,37(11):1091-1096. doi: 10.3969/j.issn.1000-6621.2015.11.002. |
[17] | 万朝敏, 儿童耐药结核杆菌感染的诊断与治疗. 中华实用儿科临床杂志, 2010,25(10):703-706. doi: 1003-515X(2010)10-0703-04. |
[18] |
Maciías Para M, Kumate Rodriíguez J, Aredondo Garciía JL, et al. Mycobacterium tuberculosis Complex Genotype Diversity and Drug Resistance Profiles in a Pediatric Population in Mexico. Tuberc Res Treat, 2011,2011:239042. doi: 10.1155/2011/239042.
doi: 10.1155/2011/239042 URL pmid: 22567263 |
[19] |
Shah NS, Auld SC, Brust JC, et al. Transmision of Extensively Drug-Resistant Tuberculosis in South Africa. N Engl J Med, 2017,376(3):243-253. doi: 10.1056/NEJMoa1604544.
doi: 10.1056/NEJMoa1604544 URL pmid: 28099825 |
[20] | 陈卉, 夏愔愔, 张灿有, 等. 2014—2018年全国学生肺结核疫情变化趋势及特征分析. 中国防痨杂志, 2019,41(6):662-668. doi: 10.3969/j.issn.1000-6621.2019.06.013. |
[21] | Soh AZ, Chee CBE, Wang YT, et al. Alcohol drinking and cigarette smoking in relation to risk of active tuberculosis:prospective cohort study. BMJ Open Respir Res, 2017,4(1):e0000247. doi: 10.1136/bmjresp-2017-000247. |
[22] | 陈晓红, 王姣焦, 沈生荣. 重视结核病患者的营养治疗. 结核与肺部疾病杂志, 2020,1(1):3-5. doi: 10.3969/j.issn.2096-8493.2020.01.002. |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||